Pallavi Upadhyay, PhD

Pallavi Upadhyay, PhD, is an infectious disease scientist and researcher, scientific and medical writer, and consultant. In her full-time role as the director of scientific and clinical affairs at HealthTrackRx company, she oversees the development and implementation of diagnostic assays and clinical studies. She also directs the research and development and scientific publication initiatives in the company. Dr. Upadhyay holds a PhD in molecular biology from Texas Woman’s University. Her professional expertise and interest include molecular diagnostics and techniques, molecular microbiology, advanced data analytics, and scientific writing.

Home
Author
Pallavi Upadhyay, PhD

Articles by Pallavi Upadhyay, PhD

Illustration of RSV particle.

Everything You Need to Know about RSV

Pallavi Upadhyay, PhD

Updates on respiratory syncytial virus (RSV), including diagnostic tools and treatment options

Illustration of a network of monkeypox coinfections on a black computer screen.

Testing for Monkeypox Virus Coinfections

Pallavi Upadhyay, PhD

Everything you need to know about monkeypox and its potential coinfections

Photograph of a HIV blood test sample tube.

Four Decades of HIV Testing: Where Do We Stand?

Pallavi Upadhyay, PhD

Rapid point-of-care tests and self-tests are critical tools toward eradicating HIV

Colored visualization of monkeypox virus electron microscopy photo.

Monkeypox: What Do We Know So Far?

Pallavi Upadhyay, PhD

Update on current monkeypox transmission, detection, prevention, and treatment

Illustration of a clinical lab professional in a lab developing a Lab Developed Test.

Current Challenges Facing Lab Developed Tests

Pallavi Upadhyay, PhD

Though challenging, creating lab developed tests is crucial for molecular diagnostics labs

Illustration of the frequency of COVID-19 variants over time

How SARS-CoV-2 Variants Impact COVID-19 Testing

Pallavi Upadhyay, PhD

Detecting novel variants can help revise and modify diagnostic tests crucial for effective patient care

COVID-19 patients with coinfections have higher mortality rates than those with single infections

The Danger of COVID-19 Coinfections

Pallavi Upadhyay, PhD

COVID-19 patients with coinfections have higher mortality rates than those with single infections

Photo of an array of novel psychoactive substances in pill form on a black background

Novel Psychoactive Substances: Testing Challenges and Strategies

Pallavi Upadhyay, PhD

To keep up with emerging NPS, toxicology labs must develop robust assays and update existing testing panels and menus

Photo of a National Health System mobile vaccination clinic bus

Mobile Drug Testing: Driving the Future of Compliance Drug Monitoring

Pallavi Upadhyay, PhD

Mobile testing frameworks could help deliver better health care to underserved communities